Alnylam Pharmaceuticals Inc. technical analysis
Technical analysis of Alnylam Pharmaceuticals Inc. (stock) with the Montbon Method — Elliott Waves, moving averages and a 0–100 score.
What is Alnylam Pharmaceuticals Inc.
Alnylam Pharmaceuticals is a US biopharmaceutical company developing therapies based on RNA interference (RNAi). It focuses on treatments for rare genetic diseases and other conditions.
Description generated automatically from public sources; it may be inaccurate or out of date.
Alnylam Pharmaceuticals Inc.: latest session data
Closing values for September 4, 2026, computed on the last 12 months of prices.
Moving averages
21 sessions
236.76 $
+12.40%
50 sessions
258.83 $
+2.81%
200 sessions
321.14 $
−17.14%
Session levels
s2
256.09
Support
s1
260.30
Support
pivot
265.74
Pivot
r1
269.95
Resistance
r2
275.39
Resistance
How to read it
In the September 4, 2026 session Alnylam Pharmaceuticals Inc. closed higher at 266.11 $, +0.61% versus the previous session.
The price sits mixed against its moving averages: +12.40% against the 21-session average, +2.81% against the 50 and −17.14% against the 200.
The 14-period RSI reads 62.2, in neutral territory.
MACD stands at 2.463 against a signal line at -3.261: the histogram is positive (+5.724).
ADX reads 15.3, indicating weak directionality.
Levels computed on the latest session place supports at 260.30 and 256.09 $ and resistances at 269.95 and 275.39 $, around a pivot of 265.74.
The average daily range (ATR) is 11.722 $, or 4.41% of price.
Turnover was 1.4M shares, 85% of the 20-session average.
Over the last twelve months the price ranged between 197.81 and 380.00 $, and today stands −29.97% from the period high.
Measures computed on closing prices. They describe the past; they are not forecasts.
Score, Elliott Waves, moving averages and technical indicators — free, no card
If you're not registered we'll ask you to sign in (free), then open the ALNY analysis.
How Montbon’s technical analysis works
Montbon analyses markets with Elliott Waves, multi-timeframe moving averages and a 0–100 score summarising the technical setup. It is an informational screening tool.
Elliott Waves
Wave counting to frame the price structure.
MTF moving averages
Moving averages across timeframes to read the trend.
0–100 score
A technical summary of the setup, updated daily.
FAQ about Alnylam Pharmaceuticals Inc.
How is Alnylam Pharmaceuticals Inc. analysed technically?
Technical analysis of Alnylam Pharmaceuticals Inc. is based on price charts and indicators such as moving averages, RSI and MACD, to observe trend, momentum and volatility across different time horizons.
Which timeframes are used for Alnylam Pharmaceuticals Inc.?
The daily and weekly charts are typically used for medium-to-long-term trends, while intraday charts (for example 1-hour or 15-minute) are used for short-term movements.
What are Elliott Waves applied to Alnylam Pharmaceuticals Inc.?
Elliott Wave theory describes price moves as sequences of impulsive and corrective waves; applied to Alnylam Pharmaceuticals Inc. it helps frame the technical structure of the historical chart and is not a forecast.
Other tickers to analyse
Disclaimer. For informational purposes only; not financial advice or a recommendation. Montbon Analytics is not an authorised financial intermediary.
Are you an issuer and want a correction or removal? Write to info@montbon.com.